Featured Research

from universities, journals, and other organizations

New Technique For Thyroid Cancer Therapy Eliminates Many Side Effects

Date:
September 20, 2004
Source:
Society Of Nuclear Medicine
Summary:
A new technique allows patients to maintain their normal course of thyroid medication prior to and during radioiodine therapy. The technique avoids the problems of hypothyroidism, and levels of radiation in the blood and bone marrow remain well below the accepted safety thresholds during therapy.

Reston, VA -- Differentiated thyroid cancer, the most common form of thyroid cancer, is one of the success stories in the war on cancer. Since the advent of radioiodine therapy, it has been considered one of the most curable cancers. On the downside, current treatment involves taking patients off their thyroid medication. This can lead to serious side effects including symptoms of hypothyroidism, an unbalanced metabolic state that can induce fatigue, depression, and other unpleasant conditions.

Bart de Keizer, MD, and a team from the University Medical Center in Utrecht, The Netherlands, and Ghent University Hospital, Belgium, reported in the September issue of The Journal of Nuclear Medicine, on a new technique that allows patients to maintain their normal course of thyroid medication prior to and during radioiodine therapy. The new technique avoids the problems of hypothyroidism, and levels of radiation in the blood and bone marrow remain well below the accepted safety thresholds during therapy.

Currently, thyroid cancer patients who have had their thyroid removed are treated with radioactive iodine, which effectively zeros in on and kills any remaining cancerous thyroid cells. But prior to radioiodine treatment, the patient must be taken off thyroid hormone replacement medication for up to 6 weeks. The withdrawal of thyroid medication signals the body to produce thyroid stimulating hormone (THS). TSH causes any remaining or metastasized thyroid cells to quickly absorb the radioactive iodine when it is administered, in effect forcing the cancerous cells to absorb lethal radioactive molecules that are largely ignored by other cells in the body.

By using a genetically engineered version of the natural hormone (recombinant human thyroid stimulating hormone [rhTSH]) instead of thyroid medication withdrawal to stimulate the cancerous cells to quickly take up the radioactive iodine, the research team in The Netherlands and Belgium found that the problems of hypothyroidism can be avoided. This new technique may also increase the safety of radioiodine treatment and may allow a higher, more effective dose of radioiodine to be used when needed. That's because when the body is not in a state of hypothyroidism, it can more efficiently process and excrete any radioiodine that hasn't been absorbed.

The study, which involved 14 patients and 17 treatments, showed that treatment with rhTSH was well tolerated. None of the patients showed blood toxicity, and no bone marrow-related side effects were noted. Blood and bone marrow are the tissues most sensitive to radiation. As expected, none of the patients showed symptoms of hypothyroidism during or following treatment.

According to Dr. de Keizer, "Using rhTSH before administering radioiodine treatments resulted in no clinically relevant side effects. Therefore, although further testing needs to be done, our findings imply this treatment should improve efficacy while preserving safety and tolerability of treatment."

###

"Bone marrow dosimetry and safety of high I-131 activities given after recombinant human thyrotropin-stimulating hormone to treat metastatic differentiated thyroid cancer" was written by Bart de Keizer, MD, Anne Hoekstra, MsC, Peter P. van Rijk, MD, PhD, and John M.H. de Klerk MD, PhD, from the Department of Nuclear Medicine, Utrecht, The Netherlands; Mark W. Konijnenberg, MsC, from Research and Development, Mallinckrodt, Tyco Healthcare, Petten, The Netherlands; Filip de Vos, MsC, and Bieke Lambert, MsC, from the Department of Nuclear Medicine, Ghent University Hospital, Belgium; and Cees J.M. Lips, MD, PhD from the Department of Endocrinology, Utrecht University Hospital, Utrecht, The Netherlands.


Story Source:

The above story is based on materials provided by Society Of Nuclear Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Society Of Nuclear Medicine. "New Technique For Thyroid Cancer Therapy Eliminates Many Side Effects." ScienceDaily. ScienceDaily, 20 September 2004. <www.sciencedaily.com/releases/2004/09/040920063817.htm>.
Society Of Nuclear Medicine. (2004, September 20). New Technique For Thyroid Cancer Therapy Eliminates Many Side Effects. ScienceDaily. Retrieved April 17, 2014 from www.sciencedaily.com/releases/2004/09/040920063817.htm
Society Of Nuclear Medicine. "New Technique For Thyroid Cancer Therapy Eliminates Many Side Effects." ScienceDaily. www.sciencedaily.com/releases/2004/09/040920063817.htm (accessed April 17, 2014).

Share This



More Health & Medicine News

Thursday, April 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Thousands Of Vials Of SARS Virus Go Missing

Thousands Of Vials Of SARS Virus Go Missing

Newsy (Apr. 16, 2014) A research institute in Paris somehow misplaced more than 2,000 vials of the deadly SARS virus. Video provided by Newsy
Powered by NewsLook.com
Formerly Conjoined Twins Released From Dallas Hospital

Formerly Conjoined Twins Released From Dallas Hospital

Newsy (Apr. 16, 2014) Conjoined twins Emmett and Owen Ezell were separated by doctors in August. Now, nearly nine months later, they're being released from the hospital. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins